NewCo & License Out - Unibest Industrial Co., Ltd.

Pipeline Scouting

We leverage our deep understanding of the Chinese pharmaceutical landscape to identify innovative drug candidates with global potential.
Investor Matchmaking

Unibest connects these carefully selected assets with global investors interested in Chinese pharmaceutical innovation.
Due Diligence

Our team conducts thorough evaluations of potential assets, ensuring only the most promising pipelines are selected for the NewCo structure.
Licensing Facilitation

We assist in structuring and negotiating licensing agreements between Chinese innovators and the NewCo entity.
Development Support

We provide ongoing support and expertise to help guide these assets through further development and potential commercialization.

The pipeline

Currently in NewCo

The current pipeline features a diverse range of assets, including antibody drugs, small molecules, and ADCs targeting various cancers and autoimmune diseases from preclinical to Phase II.

We have also selected few commercial stage products markets in China open for licensing.

Download Assets

meeting

Interested for Licensing

Interested in one of our innovative pipelines? Let's discuss your licensing opportunities in depth. Schedule a meeting with Unibest experts to explore how we can collaborate on bringing cutting-edge pharmaceuticals to global markets.

Reserve A Meeting